QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:DSGN

Design Therapeutics (DSGN) Earnings Date, Estimates & Call Transcripts

$5.51
-0.25 (-4.34%)
(As of 06/5/2023 ET)
Compare
Today's Range
$5.47
▼
$5.98
50-Day Range
$4.99
▼
$7.64
52-Week Range
$4.90
▼
$26.30
Volume
126,504 shs
Average Volume
381,193 shs
Market Capitalization
$308.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(Mar. 14)
-$0.31 Beat By $0.03
Consensus EPS
(Mar. 14)
-$0.34
Last Year's Q1 EPS
(3/10/2022)
-$0.20
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

DSGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DSGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Design Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.38)($0.28)($0.34)
Q2 20232($0.42)($0.31)($0.37)
Q3 20233($0.46)($0.32)($0.41)
Q4 20232($0.50)($0.32)($0.41)
FY 202310($1.76)($1.23)($1.53)
Q1 20241($0.46)($0.46)($0.46)
Q2 20241($0.48)($0.48)($0.48)
Q3 20241($0.50)($0.50)($0.50)
Q4 20241($0.48)($0.48)($0.48)
FY 20244($1.92)($1.92)($1.92)

DSGN Earnings Date and Information

Design Therapeutics last released its earnings data on March 14th, 2023. The reported ($0.31) earnings per share for the quarter, topping analysts' consensus estimates of ($0.34) by $0.03. Design Therapeutics has generated ($1.25) earnings per share over the last year (($1.25) diluted earnings per share). Earnings for Design Therapeutics are expected to decrease in the coming year, from ($1.66) to ($2.02) per share. Design Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off prior year's report dates.

Design Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2023
(Estimated)		        
3/14/2023Q4 2022($0.34)($0.31)+$0.03($0.31)
11/3/2022Q3 2022($0.28)($0.32)($0.04)($0.32)
8/8/2022Q2 2022($0.25)($0.27)($0.02)($0.27)
5/9/2022Q1 2022($0.22)($0.24)($0.02)($0.24)
3/10/2022Q4 2021($0.22)($0.20)+$0.02($0.20)
11/9/20219/30/2021($0.14)($0.21)($0.07)($0.21)
8/9/20216/30/2021($0.18)($0.14)+$0.04($0.14)
5/10/2021Q1 2021($0.06)($0.31)($0.25)($0.31)












Design Therapeutics Earnings - Frequently Asked Questions

When is Design Therapeutics's earnings date?

Design Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off last year's report dates. Learn more on DSGN's earnings history.

Did Design Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Design Therapeutics (NASDAQ:DSGN) reported ($0.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.34) by $0.03. Learn more on analysts' earnings estimate vs. DSGN's actual earnings.

How much revenue does Design Therapeutics generate each year?

Design Therapeutics (NASDAQ:DSGN) has a recorded annual revenue of $230,000.00.

How much profit does Design Therapeutics generate each year?

Design Therapeutics (NASDAQ:DSGN) has a recorded net income of -$63.31 million. DSGN has generated -$1.25 earnings per share over the last four quarters.

What is Design Therapeutics's EPS forecast for next year?

Design Therapeutics's earnings are expected to decrease from ($1.66) per share to ($2.02) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:DSGN) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -